-
Drosophila Keap1–Lamin Control of Nuclear Architecture
2026-08-22
Carlson and colleagues identify a functional interaction between Drosophila Keap1 and the B-type lamin Dm0, extending Keap1 biology beyond oxidative and xenobiotic transcriptional responses. Their perturbation and genetic data connect dKeap1 mis-regulation with lamin redistribution, heterochromatin expansion, nuclear-lamina defects, and developmental phenotypes.
-
Dietary Arachidonic Acid Boosts Vaccine Immunity
2026-08-22
The reference study shows that dietary arachidonic acid accelerates and strengthens rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the identification of a lymph-node ARA–prostaglandin I2–cAMP/PKA pathway that enhances B-cell activation, germinal-center responses, and antibody maturation.
-
From BATF2–ATF3 to Translational Protein Interactions
2026-08-21
The BATF2–ATF3 axis offers a mechanistic entry point into intervertebral disc degeneration, but translational confidence depends on proving protein associations in disease-relevant samples. This article explains how magnetic co-immunoprecipitation, rigorous controls, and orthogonal validation can convert pathway observations into actionable protein-protein interaction evidence.
-
AZD8055: Practical mTOR Inhibitor Workflow Guide
2026-08-20
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling in cell and animal models. It is useful for mechanistic pathway work, but its water insolubility, need for fresh DMSO solutions, and minimal clinical benefit make it unsuitable as evidence of clinical efficacy.
-
T-5224: C-Fos/AP-1 Inhibitor Guide
2026-08-20
T-5224 is a selective C-Fos/AP-1 inhibitor that blocks c-Fos/c-Jun DNA binding and suppresses inflammatory and osteoclastogenic readouts. Product data support its use in arthritis research, including collagen-induced arthritis models, while direct application to neuroinflammatory pain remains unvalidated.
-
Anlotinib Hydrochloride in Translational Angiogenesis
2026-08-19
An evidence-led perspective on how Anlotinib hydrochloride connects VEGFR2, PDGFRβ, FGFR1, ERK signaling, and endothelial phenotypes into a practical translational research strategy.
-
Senescent Liver Stress Under Alcohol and ART
2026-08-19
Chen and colleagues show that hepatocyte senescence and organismal aging amplify cellular stress and injury caused by alcohol, ritonavir, lopinavir, and hippuric acid. The study’s value lies in comparing young and aged liver contexts while integrating ER-stress, metabolic, deubiquitinase, injury, and senescence readouts.
-
Cabozantinib in RCC: Assay Design and Adaptation
2026-08-18
Use Cabozantinib (XL184) to interrogate VEGFR, MET, RET, AXL, and related receptor tyrosine kinase networks across acute, chronic, angiogenesis, and motility assays. A time-resolved workflow helps distinguish direct pathway suppression from adaptive remodeling in renal cell carcinoma models.
-
HBsAg, TBK1, and Autophagy in Chronic HBV
2026-08-18
A 2025 Cell Death and Disease study identifies TBK1 as a mechanistic branchpoint exploited by hepatitis B surface antigen (HBsAg). HBsAg enhances TBK1 dimerization while uncoupling TBK1 from IRF3, thereby suppressing type I interferon and promoting incomplete autophagy that supports HBV persistence.
-
CDK4/6 and BET Synergy in Pancreatic Cancer
2026-08-17
Gu et al. show that palbociclib alone can restrain pancreatic tumor-cell proliferation while unexpectedly enhancing migration, invasion, and epithelial-to-mesenchymal transition. Combining CDK4/6 inhibition with the BET inhibitor JQ1 produced synergistic tumor growth suppression by counteracting GSK3β-mediated Wnt/β-catenin signaling and its interaction with TGF-β/Smad pathways.
-
Doxycycline as a Translational Research Lever
2026-08-17
Doxycycline is more than a familiar tetracycline antibiotic: its antimicrobial activity, metalloproteinase inhibition, and context-dependent antiproliferative effects make it a versatile translational research compound. This article connects those mechanisms with targeted nanomedicine findings while clearly separating evidence established for doxycycline from hypotheses inspired by a recent peptide-delivery study.
-
Wortmannin Workflows for PI3K Signaling Studies
2026-08-16
Wortmannin provides a rapid, mechanistically informative way to perturb PI3K/Akt signaling in cell-based cancer research, apoptosis assays, and ferroptosis studies. This practical guide connects pathway inhibition with FAT4-deficient hepatocellular carcinoma models while emphasizing dosing, controls, solubility, and interpretation.
-
Measuring Cancer Drug Responses In Vitro
2026-08-15
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent dimensions of an in vitro drug response. Its central practical contribution is a measurement framework that incorporates response magnitude, biological composition, and timing before assigning mechanistic meaning to drug sensitivity.
-
7-Ethyl-10-hydroxycamptothecin: Practical Assay Guide
2026-08-14
Build mechanism-led in vitro studies with 7-Ethyl-10-hydroxycamptothecin, from controlled DMSO dosing to apoptosis and cell-cycle profiling. The workflow combines topoisomerase I biology with the FUBP1–FUSE finding reported for SN-38, creating a stronger framework for advanced colon cancer research.
-
Mouse Neutrophil Cell Isolation Kit for Tumor Studies
2026-08-14
Build fast, low-perturbation neutrophil preparations for tumor immunology, nanoparticle testing, and functional assays. This guide combines the negative-selection workflow with practical controls, source-specific optimization, and troubleshooting for reproducible high-purity neutrophil isolation.